PAM
IMUX icon

Panagora Asset Management’s Immunic IMUX Stock Holding History

Panagora Asset Management’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-7
Closed -$1K – 2859
2020
Q3 		$1K Hold
7
– – ﹤0.01% 2646
2020
Q2 		$1K Hold
7
– – ﹤0.01% 2510
2020
Q1 		$0 Hold
7
– – ﹤0.01% 2552
2019
Q4 		$1K Hold
7
– – ﹤0.01% 2401
2019
Q3 		$1K Buy
+7
New +$937 ﹤0.01% 2410
2014
Q4 		– Sell
-9
Closed -$78K – 2311
2014
Q3 		$78K Sell
9
-14
-61% -$132K ﹤0.01% 1924
2014
Q2 		$248K Buy
+23
New +$161K ﹤0.01% 1643

Other funds holding IMUX

OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
ACM
Altium Capital Management New York $47.5M AUM 115.72% 1-Year Est. Return

Panagora Asset Management's IMUX Position: Q4 2020 in Review

Panagora Asset Management sold out of Immunic (IMUX) in Q4 2020, closing a stake of 7 shares — an estimated $1K sold.

Panagora Asset Management first reported a position in IMUX in Q2 2014 and held it in 7 quarters. The position peaked at $248K in Q2 2014. 69 funds tracked by Wall St. Rank hold IMUX as of Q4 2020.

  • Panagora Asset Management reported no remaining Immunic position as of Q4 2020 after selling out during the quarter.
  • Panagora Asset Management sold 7 Immunic shares in Q4 2020, an estimated $1K.
  • Panagora Asset Management first reported a position in Immunic in Q2 2014 and held it in 7 quarters.
  • Panagora Asset Management's Immunic position peaked at $248K in Q2 2014.
  • 69 funds tracked by Wall St. Rank held Immunic as of Q4 2020.

Based on Panagora Asset Management's 13F filing for Q4 2020, filed 10 Feb 2021.